Retatrutide, a new dual stimulator of the GLP-1 binding site and glucose-dependent insulinotropic polypeptide (GIP) target, is showing promising results in initial human trials . Ongoing research https://agendabookmarks.com/story21299473/retatrutide-emerging-investigations-and-possible-medical-roles